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A B S T R A C T
Proopiomelanocortin (POMC) is a key mediator of satiety. Epigenetic marks such as DNA methylation may
modulate POMC expression and provide a biological link between early life exposures and later phenotype.
Animal studies suggest epigenetic marks at POMC are inﬂuenced by maternal energy excess and restriction,
prenatal stress and Triclosan exposure. Postnatal factors including energy excess, folate, vitamin A, conjugated
linoleic acid and leptin may also aﬀect POMC methylation. Recent human studies suggest POMC DNA methy-
lation is inﬂuenced by maternal nutrition in early pregnancy and associated with childhood and adult obesity.
Studies in children propose a link between POMC DNA methylation and elevated lipids and insulin, independent
of body habitus. This review brings together evidence from animal and human studies and suggests that POMC is
sensitive to nutritional programming and is associated with a wide range of weight-related and metabolic
outcomes.
1. Background
Proopiomelanocortin (POMC), a pro-hormone, gives rise to nu-
merous active peptides and hormones with a wide range of physiolo-
gical actions (Toda et al., 2017). In the brain, POMC is expressed in the
arcuate nucleus (ARC) of the hypothalamus, the pituitary gland and the
brain stem. Tissue-speciﬁc post-translational proteolysis of POMC gives
rise to the active hormones ACTH (adrenocorticotropic hormone), α-,
β– and γ- MSH (melanocyte stimulating hormone) and β – endorphin
(see Fig. 1). Diﬀerent populations of POMC neurons produce diﬀerent
amounts of the active hormones dependent on the expression levels of
prohormone convertases e.g. corticotrophs of the anterior pituitary
produce predominantly ACTH, whereas melanotrophs of the hypotha-
lamus produce predominantly α- and β-MSH (Toda et al., 2017; Cone,
2005).
POMC is a key component of the melanocortin system (Mountjoy,
2015); a complex network of systemic signals and neural pathways that
regulate food intake and energy balance (see Fig. 2). POMC neurons in
the ARC of the hypothalamus integrate peripheral signals such as leptin
(Balthasar et al., 2004), glucose (Parton et al., 2007) and insulin (Qiu
et al., 2014), and regulate energy balance by inducing satiety and in-
creasing energy expenditure (Toda et al., 2017). Satiety is mediated via
the actions of α- and β-MSH on melanocortin 4 receptors (MC4R) in the
paraventricular nucleus (PVN) of the hypothalamus (Schioth et al.,
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2002; Biebermann et al., 2006). An opposing group of orexigenic
neurons (Agouti-related peptide (AgRP) and neuropeptide-Y (NPY))
receive systemic inputs from ghrelin (released from enteroendocrine
cells) and have the opposite action by increasing appetite and de-
creasing energy expenditure by antagonising MC4R and by direct in-
hibition of satiety neurons in the PVN (Toda et al., 2017; Andermann
and Lowell, 2017). Perturbations of the melanocortin system can lead
to disorders of energy balance such as obesity. For example, individuals
with bi-allelic loss of function mutations in POMC demonstrate early
hyperphagia, severe obesity (due to α-/β-MSH deﬁciency) and central
adrenal insuﬃciency (due to ACTH deﬁciency) (Krude et al., 1998). It
has been demonstrated that heterozygote variant carriers have an in-
creased risk of developing obesity but with no adrenal insuﬃciency
(Farooqi et al., 2006; Krude et al., 2003) suggesting a gene dosage eﬀect
on energy balance.
Epigenetic processes, including DNA methylation, histone mod-
iﬁcation, chromatin remodelling and RNA-based mechanisms can aﬀect
gene expression (Gibney and Nolan, 2010). DNA methylation is widely
studied in animals and humans and occurs primarily at cytosine-gua-
nine (CG) dinucleotides (CpG methylation). DNA methylation is usually
associated with condensed heterochromatin and subsequent gene si-
lencing or reduced gene expression (Jones, 2012). DNA methylation is
mitotically heritable (Riggs and Porter, 1996) and is inﬂuenced by
genetic and environmental factors (Hannon et al., 2018; Jaenisch and
Bird, 2003; James et al., 2018).
In humans, the POMC gene is found on chromosome 2p23 and
consists of three exons. Exon 3 codes for the majority of translated
mRNA (see Fig. 1) and functionally-relevant peptides i.e. ACTH, α-/β-
MSH, β – endorphin (Takahashi et al., 1983). The gene contains two
CpG islands (areas of the genome with high CpG density), the ﬁrst in
the 5′-promoter region and the second at the boundary of intron2/
exon3 (Kuehnen and Krude, 2012).
POMC expression is controlled by diﬀerent and independent tran-
scriptional enhancers in the pituitary and hypothalamus (de Souza
et al., 2005) (see Fig. 1). Of particular relevance to POMC’s role in
energy balance is regulation of gene expression in the hypothalamus. In
the hypothalamus, two proximal enhancers; neural POMC enhancer 1
(nPE1) and 2 (nPE2) regulate POMC expression. nPE1 contains a STAT3
(Signal transducer and activator of transcription – 3) binding site, im-
portant for leptin signalling. Leptin’s transcriptional activation of POMC
is dependent on the Janus kinase (JAK)-STAT pathway with STAT 3 and
5 especially relevant for mediating satiety (Ladyman and Grattan,
2013). STAT activation of POMC transcription is also dependent on
Speciﬁcity Protein 1 (Sp1) binding to a region in the POMC promoter
(Yang et al., 2009). nPE2 is a shorter genomic region and contains a
binding site for the estrogen-related receptor alpha (ERRα) (de Souza
et al., 2005; Drouin, 2016). These enhancer and promoter binding re-
gions are functionally conserved in rodents and humans (de Souza
et al., 2005; Hill, 2010; Bumaschny et al., 2007). In both humans and
mice, additional transcriptional enhancer activity has also been iden-
tiﬁed at the boundary of intron2/exon3. This region contains a histone
acetyltransferase p300 complex binding site that is associated with gene
activation (Kuehnen et al., 2012; Lacaze-Masmonteil et al., 1987). The
majority of animal studies (see Tables 1 and 2) concentrate on the
promoter region, but more recently, human studies have examined
other regulatory regions.
Due to POMC’s involvement in multiple physiological processes,
epigenetic changes at POMC are associated with a diverse range of
Fig. 1. Human POMC Gene; transcription, translation and post-translational processes. The human POMC gene consists of 3 exons and 2 large introns and is located
between chromosome 2:25,383,722 to 25,391,722 (hg19, reverse strand). There are two CpG islands related to the POMC gene; the ﬁrst in the promoter region and
second over the boundary of intron2/exon3. Exon 1 (87 bp) contains a non-coding sequence and produces a short leader sequence that binds the ribosome at the start
of translation. Exon 2 (152 bp) gives rise to a small signal peptide and forms the N-terminal end of the POMC peptide. Exon 3 (835 bp) produces the majority of the
POMC peptide as well the signal for the addition of the poly-A tail. The ﬁgure provides schematic representation of the key transcriptional enhancers and binding
sites related to leptin signalling and hypothalamic expression of neuropeptides (discussed in this article). Key: CpG; cytosine-guanine dinucleotide, Alu; Alu element,
P300; P300 complex binding domain, POMC; Proopiomelanocortin, PC1; Prohormone convertase 1, PC2; Prohormone convertase 2, -MSH; -melanocyte stimulating
hormone, ACTH; Adrenocorticotropic hormone, CLIP; corticotropin-like intermediate peptide, AAA-tail; poly-A tail, nPE; neuro POMC enhancer, STAT3, Signal
transducer and activator of transcription 3, ERRα; estrogen-related receptor alpha, Sp1; Speciﬁcity Protein 1, E2F; E2 Factor, RELA; v-rel reticuloendotheliosis viral
oncogene homologue A (avian).
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phenotypes. In this review, we present evidence linking epigenetic
regulation of POMC to nutritional programming, obesity, energy bal-
ance and metabolic outcomes.
2. Methods
A MEDLINE database search was conducted using the following
search terms; (((epigen*) OR methylation)) AND (((POMC) OR
Proopiomelanocortin) OR Pro-opiomelanocortin)) on 12th November
2018. This search produced 181 articles. The purpose of this systematic
narrative review is to summarise the evidence, in both animals and
humans, of epigenetic regulation of POMC relevant to nutritional pro-
gramming, energy balance, obesity and metabolic outcomes. Therefore,
only articles that referred to obesity, body weight or BMI (body mass
index) or energy balance, adiposity, lipid or glucose metabolism were
subsequently included. Articles concerning intergenerational or trans-
generational processes were also included as these are relevant to nu-
tritional programming. Articles with no speciﬁc reference to POMC
epigenetic processes (such as DNA methylation or histone modiﬁca-
tions) were excluded. Reference sections of included studies were also
reviewed, and additional relevant papers were included if not found
during the initial MEDLINE search.
3. Animal studies
3.1. Prenatal exposures, epigenetic alterations in the POMC gene and
oﬀspring phenotype
Animal studies have allowed researchers to manipulate the fetal
environment and examine subsequent postnatal phenotypes under
controlled conditions. Fetal adaptation to the in utero environment may
present a survival advantage by the organism being better prepared for
the anticipated ex utero environment (Gluckman and Hanson, 2004).
For example, a consequence of fetal adaptation to prenatal energy re-
striction might be for oﬀspring to be better adapted to postnatal nu-
tritional scarcity by, for instance, maintaining a smaller body size and
having greater energy eﬃciency and increased appetite. This could
result in later obesity if there is a mismatch between in utero and ex
utero environments and forms the basis of the predictive adaptive re-
sponse (PAR) hypothesis (Gluckman et al., 2005). Alternatively, en-
vironmentally induced epigenetic changes may simply be a con-
sequence of the exposure on normal epigenetic development (Guerrero-
Bosagna, 2017). Either way, a better understanding of how epigenetic
mechanisms can mediate links between prenatal exposures and post-
natal phenotype will have important implications for human health. A
number of animal studies have examined how altering the in utero
nutritional and/or prenatal environment inﬂuences POMC epigenetic
marks and the subsequent phenotype in the oﬀspring (see Table 1).
3.1.1. Maternal energy excess
Maternal overnutrition, induced by feeding pregnant rats high en-
ergy diets, has been shown to lead to persistent changes in oﬀspring
phenotype with accompanying epigenetic changes (Gali Ramamoorthy
et al., 2018; Marco et al., 2014; Zheng et al., 2015).
Rat pups exposed to high fat diet (HFD) in utero have higher POMC
DNA methylation and a shift towards an obese phenotype as adults.
This was demonstrated in a study by Marco et al. (2014) who showed
that, compared to controls, the oﬀspring of mothers fed HFD in preg-
nancy had a higher birth weight, ate more postnatally and had higher
body weight up to 110 days of age. Oﬀspring from the HFD group
Fig. 2. Schematic diagram of the melanocortin system and the control of appetite and satiety. At the level of the hypothalamus, appetite and satiety regulating
neurons (POMC, AgRP/NPY) of the arcuate nucleus (ARC) send projections to the paraventricular nucleus (PVN), The anorectic POMC expressing neurons are
responsive to systemic signals including leptin, insulin and metabolites (such as glucose), α and β-MSH (derived from POMC) mediates the satiety signal via the
action on MC4R. AgRP/NPY expressing neurons respond to ghrelin (which is predominantly under the control of the autonomic nervous system (ANS)), a hormone
released by enteroendocrine cells that acts to increase appetite. AgRP antagonises the action of α-MSH at MC4R, whilst the neurotransmitters NPY and GABA convey
an orexigenic signal via PVN neurons. Meal termination (satiation) is brought about via activation of vagal aﬀerents from stomach stretch receptors and nutrient-
induced release of enteroendocrine factors (CCK, 5HT, PYY, GLP-1). The vagal aﬀerents send projections to the NTS (nucleus tractus solitarii) to bring about meal
termination. Abbreviations: POMC; Proopiomelanocortin, AgRP; Agouti-related peptide, NPY; neuropeptide-Y, α-MSH; alpha-melanocyte stimulating hormone, β-
MSH; beta-melanocyte stimulating hormone, MC4R; melanocortin 4 receptors, GABA; gamma-aminobutyric acid, NTS; nucleus tractus solitarii, CCK; cholecysto-
kinin, 5HT; 5-hydroxytryptamine, PYY; Peptide YY, GLP-1; glucagon-like peptide 1, ARC; arcuate nucleus of the hypothalamus, PVN; paraventricular nucleus of the
hypothalamus, ANS; autonomic nervous system.
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demonstrated ARC POMC hypermethylation across the promoter region
(with signiﬁcantly higher methylation in 5 CpGs) and this hy-
permethylation was maintained into adulthood suggesting that POMC
methylation is a stable epigenetic mark. When these pups were subse-
quently exposed to an HFD challenge, they consumed more and gained
more weight than oﬀspring of controls. Despite diﬀerences in POMC
methylation, there were no diﬀerences in POMC expression. However,
the HFD group had higher levels of leptin though this did not lead to
higher POMC expression as might be expected. Only female oﬀspring
were examined for the hormonal, POMC expression and methylation
analyses. This study provides evidence of an association between POMC
hypermethylation (inﬂuenced by prenatal HFD) and increased body
weight in oﬀspring.
A further study by Marco et al. (2016), replicated the earlier ﬁnding
that oﬀspring of HFD fed rats had higher body weight into adulthood
and had higher ARC POMC promoter methylation (with signiﬁcantly
higher methylation in 3 CpGs) compared to controls, but went further
by postulating a process of dual epigenetic silencing with higher levels
of H3K9me2 (an epigenetic mark associated with transcriptional re-
pression) at the POMC promoter in the ARC. These epigenetic changes
were associated with lower POMC expression and higher body weight.
Interestingly, lean control oﬀspring had higher levels of 5-hydro-
xymethylcytosine (5hmC), an epigenetic mark predominantly found in
the central nervous system that is associated with increased gene
transcription (Shi et al., 2017; Mellen et al., 2012). Body weight was
positively correlated with POMC promoter 5-methylcytosine (5mC) and
negatively correlated with POMC promoter 5hmC levels. The study also
demonstrated higher levels of methyl binding domain protein 1 (MBD1)
binding in the POMC promoter and SET domain binding 1 (SETDB1, a
histone methyltransferase) in HFD oﬀspring and showed that this
complex of MBD1 and SETDB1 promoted histone methylation. There
were lower levels of the MBD1-SETDB1 complex in lean controls, sug-
gesting that higher levels of 5hmC inhibited binding at this region
leading to greater expression of POMC and a stronger satiety signal.
This study gives evidence of an association between levels of 5mC and
5hmC in the POMC promoter and oﬀspring’s body weight. It further
supports a relationship between prenatal HFD exposure and increased
levels of 5mC in the POMC promoter.
In those exposed to a high energy diet in utero, a high energy diet
postnatally may have a modulatory eﬀect on POMC methylation.
Evidence for this came from Zheng et al. (2015) who produced two
groups of rats; FS-FS (high fat, high sucrose diet fed to mothers and
oﬀspring from weaning) and C-C (control diet fed to mothers and oﬀ-
spring from weaning). The FS-FS group demonstrated higher body
weight in adulthood, though with higher expression of POMC and lower
average methylation of the POMC promoter compared to controls
(mean methylation ± SD=FS-FS 37.5 ± 1.7% vs C-C 46.3 ± 3.5%,
p=0.03). Despite examining the same genomic region, this is diﬀerent
to the observation reported by Marco et al. (2014, 2016), where in-
creased POMC methylation was reported in oﬀspring exposed to HFD in
utero. In the studies by Marco et al. (2014, 2016), pups were weaned
onto a normal calorie diet (not high energy) and therefore the disparate
postnatal diets may explain the diﬀerence in POMC methylation re-
ported following high energy exposure in utero. Another potential ex-
planation is that Zheng et al. (2015) studied male rats from weaning, in
contrast to the use of female rats (for hormonal and POMC expression/
methylation analysis) examined in Marco et al. (2014).
Further evidence of diﬀerential eﬀects of pre- and postnatal dietary
exposures on oﬀspring POMC methylation was highlighted in a recent
study by Gali Ramamoorthy et al. (2018) who reported hypermethy-
lation in the POMC promoter and enhancer regions in 3-week-old male
pups from HFD fed mothers. This methylation pattern in the promoter
(but not the enhancer) was conserved into adulthood and suggests a
potential critical period of prenatal programming. In this study, post
weaning HFD also led to hypermethylation in the POMC promoter of
male pups from the control group, though there were no additive eﬀects
of post-weaning HFD on POMC methylation in pups exposed to HFD
prenatally. This study gives further evidence that maternal HFD is as-
sociated with increased methylation at regulatory regions of POMC and
that increased POMC methylation is associated with increased body
weight and food intake into adulthood.
Other epigenetic pathways have been shown to be inﬂuenced by
maternal HFD. Desai et al. (2016), showed lower expression of hy-
pothalamic DNA methyltransferase 1 (DNMT1) and histone deacetylase
(HDAC, a class of enzyme that removes acetyl groups from histones and
is associated with gene suppression) in oﬀspring exposed to HFD in
utero. In this study, as expected, male oﬀspring of HFD mothers, when
milk fed by the same HFD mothers, developed markedly increased
weight and adiposity compared to controls. On day 1 of life, those
oﬀspring from HFD fed mothers showed lower expression of hypotha-
lamic DNMT1 and increased AgRP expression compared to controls.
However, POMC expression was the same in both groups. By 6months,
hypothalamic levels of HDAC were signiﬁcantly reduced in the oﬀ-
spring of HFD mothers. The higher expression of AgRP was maintained
but now also with reduced POMC expression compared to controls. This
study provides additional evidence that prenatal HFD inﬂuences oﬀ-
spring’s epigenetic processes at POMC. The changes were not associated
with altered POMC expression until adulthood, though there were
marked diﬀerences in body weight between the two groups.
As well as eﬀects on oﬀspring bodyweight and adiposity, maternal
high energy diet has been shown to lead to impaired glucose home-
ostasis and greater insulin resistance in progeny. This has been evi-
denced by Gali Ramamoorthy et al. (2018) who reported greater insulin
resistance from 8weeks of age that persisted into adulthood in rats
exposed to HFD in utero. Furthermore, Zheng et al., demonstrated that
POMC methylation was negatively associated with glucose response to
a glucose load in a study in rats (Zheng et al., 2015).
In summary, there is a strong evidence of an association between
prenatal HFD and oﬀspring hypermethylation in regulatory regions of
POMC that persist until adulthood (Gali Ramamoorthy et al., 2018;
Marco et al., 2014, 2016). A potential modulatory eﬀect of postnatal FS
diet on POMC methylation has been reported (Zheng et al., 2015),
however Gali Ramamoorthy et al. (2018) demonstrated no additional
inﬂuence from a postnatal high energy diet on the hypermethylation
already seen in those with prenatal HFD exposure.
3.1.2. Maternal energy restriction
Maternal undernutrition was ﬁrst demonstrated to be associated
with oﬀspring POMC hypomethylation and increased histone acetyla-
tion of H3K9 (associated with increased gene transcription), by Stevens
et al. using a sheep model with analysis of fetal hypothalamic tissue
(Stevens et al., 2010). However, these observed epigenetic changes
were not associated with any change in POMC expression compared to
controls (normally fed ewes). Importantly, their study found that al-
terations to the periconceptional nutritional environment, even when
applied to a narrow window, can alter POMC gene methylation in later
pregnancy. The study demonstrated that undernutrition exposure from
as little as 2 days and up to 30 days before conception, was associated
with signiﬁcant POMC hypomethylation (64% lower than controls) in
fetuses by day 133–135 of gestation. Pregnancies were terminated be-
tween day 131–135 of gestation, so an assessment of the postnatal
phenotype was not made. Though 10-month old sheep from under-
nourished mothers (using the same protocol), had impaired glucose
handling and increased body weight, it is not known if this was asso-
ciated with alterations in POMC methylation or expression (Todd et al.,
2009).
Begum et al. (2012), replicated the ﬁndings of POMC hypomethy-
lation and increased H3K9 acetylation but also reported lower DNMT
activity in the hypothalamus of both male and female oﬀspring of en-
ergy restricted ewes (restricted between day −60 to +30 relative to
conception). Similar to Stevens et al., the fetuses were euthanised be-
tween day 131–135 of gestation so there was no assessment of postnatal
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phenotype, however this study gives further evidence of an eﬀect of
periconceptional undernutrition on oﬀspring’s epigenetic marks at the
POMC gene.
However, Coupé et al. (2010) reported no changes in DNA methy-
lation in hypothalamic feeding-related genes including in the POMC
promoter or enhancer regions, in the postnatal male rat hypothalamus
in intrauterine growth restricted rats. Though the exact timing of ca-
loriﬁc restriction was not clear, this would not support a modulatory
eﬀect of undernutrition on POMC methylation in rats.
Sex speciﬁc alterations in POMC expression are reported in oﬀspring
of energy restricted sheep, though the mechanism remains unclear.
Begum et al. (2013) found that adult sheep exposed to undernutrition in
early pregnancy demonstrated lower POMC expression in males (with
increased fat mass in adulthood) but no diﬀerence in females (Begum
et al., 2013). However, there was no assessment of POMC methylation
as a mediator of these changes in gene expression. Óvilo et al. (2014)
found female oﬀspring (but not males) of late gestation nutritionally-
restricted Iberian sows had a lower hypothalamic expression of POMC.
There was increased body weight and fat but again there was no
measurement of POMC methylation. Sexual dimorphism in hypotha-
lamic circuits has been described and extensively reviewed (Chowen
et al., 2019). Deletion of ERRα from POMC neurons has no eﬀect on
male mice but leads to increased body weight, hyperphagia and in-
creased lean mass in females (Xu et al., 2011). One possibility is that
epigenetic changes involving the ERR are responsible for the sexual
dimorphic response to maternal energy restriction. Alternatively, cir-
culating estrogen could modulate the central actions of insulin or glu-
cose on POMC neurons postnatally (Ramamoorthy et al., 2015).
In summary, there is strong evidence from the studies of Stevens
et al. (2010) and Begum et al. (2012) to suggest that periconceptional
undernutrition has a modulatory eﬀect on late gestational POMC epi-
genetic marks including hypomethylation, increased H3K9 acetylation
and lower DNMT activity. There is limited evidence of an association
between these changes and a subsequent postnatal phenotype. Evidence
of phenotypic changes were highlighted by Begum et al. (2013), with
higher fat mass and lower POMC expression in oﬀspring of energy re-
stricted ewes but it is not clear if this was mediated by epigenetic
changes at POMC (Begum et al., 2013).
3.1.3. Mismatch in pre and postnatal vitamin and folate diet
A set of interlocking pathways, collectively known as one-carbon
metabolism, provide methyl groups for methylation reactions including
the methylation of cytosine bases and histone tails that in turn inﬂuence
gene expression. These methylation reactions are controlled by me-
thyltransferases that act on methyl groups produced by the conversion
of S-adenosyl methionine (SAM) to S-adenosyl homocysteine (SAH).
One-carbon metabolism is dependent on a number of nutrients and
vitamins including folate, B12, B6, B2 and choline (Friso et al., 2017
Apr) (see Fig. 3). It has been postulated that alterations in folate or
other one-carbon metabolite levels pre or postnatally could mediate
epigenetic changes, putatively by altering the availability of methyl
groups. For example in humans, maternal concentrations of folate in
early pregnancy have been associated with oﬀspring’s DNA methylation
and birth weight, illustrating the potential importance of prenatal ex-
posure to one-carbon related nutrients and vitamins on DNA methyla-
tion and phenotype (Hoyo et al., 2014).
A mismatch between a high vitamin diet (HV) in utero and re-
commended vitamin diet (RV) in postnatal life has been shown to be
associated with obesity in rats (Cho et al., 2013a; Sanchez-Hernandez
et al., 2015, 2014). Maintaining a similarly high vitamin intake in the
postnatal diet can attenuate the development of the obese phenotype
and can normalise POMC expression to that of controls. This was ele-
gantly shown in a rat model by Cho et al. (2013a) who showed that
male oﬀspring of rats fed HV, a 10-fold higher recommended intake of
multivitamins (‘AIN-93G’ containing 13 vitamins (Reeves, 1997) in-
cluding Vitamin A, D, Riboﬂavin, Choline and Folic acid) in pregnancy,
who were then weaned to RV, demonstrated higher body weight, food
consumption and higher glucose response to a glucose load than those
born to mothers fed the RV intake in pregnancy. Conversely, HV or
HFol (high folate) postnatally prevented these associated phenotypic
changes. Interestingly, postnatal HFol diet did not normalise POMC
expression as the HV diet did. There was no diﬀerence in global hy-
pothalamic DNA methylation between any of the dietary groups,
though POMC methylation was not measured speciﬁcally.
Furthermore, it has been shown that HFol diet postnatally, alters
POMC methylation in rats. This was evidenced by Cho et al. (2013b),
who gave male oﬀspring of mothers fed HFol diet, either RV or HFol
and compared them to controls fed RV pre and postnatally. HFol-RV
rats demonstrated signiﬁcantly higher food intake and body weight
compared to controls and a 20% lower glucose response to an insulin
load at 7 weeks of age (no diﬀerences at week 12 or 16 of life). HFol-
HFol rats showed lower food intake and body weight compared to
controls and demonstrated a signiﬁcantly lower glucose response to a
glucose load compared to HFol-RV and controls at week 10 (though no
diﬀerences at week 14 or 18 of life). HFol in gestation reduced hy-
pothalamic POMC expression compared to RV. The HFol – HFol groups
had lower hypothalamic POMC methylation compared to the RV-RV
and HFol-RV groups, providing evidence for ongoing postnatal plasti-
city in POMC DNA methylation mediated by increased dietary folate
(even though global DNA methylation was not altered). It should be
noted that although statistically signiﬁcant, the diﬀerences in POMC
methylation between the groups were small (HFol-HFol had 4% lower
mean methylation compared to the other groups). This study supports
an association between POMC methylation and a glucose response to a
glucose load (glucose to POMC methylation coeﬃcient of 0.7,
p= 0.03).
There is evidence that vitamin A can mediate epigenetic changes as
it can increase glycine N-methyltransferase enzyme expression, which
can lead to loss of methyl groups (Rowling et al., 2002). In male rats
exposed to a HV diet in utero, a postnatal diet high in vitamin A (HA, 10-
fold higher vitamin A than recommended) can lower methylation at
POMC, as demonstrated by Sánchez-Hernández et al. (2014). This study
found that postnatal diets of either HV or HA, led to reduced post
weaning weight gain and reduced food intake compared to male rats
fed RV diets. HA postnatal diet was associated with signiﬁcantly lower
hypothalamic POMC promoter methylation compared to RV and HV,
though the diﬀerence in mean methylation between the groups was
small (3%). HV postnatal diet was associated with higher levels of
POMC expression compared to RV but there was no diﬀerence in POMC
expression between HV and HA diet. Though higher POMC gene ex-
pression was seen in the HV group compared to the control group, there
was no diﬀerence in POMC promoter methylation, suggesting other
epigenetic mechanisms (e.g. histone modiﬁcations) could account for
the diﬀerence in expression. This study does support a modest eﬀect of
a postnatal HA diet in lowering mean POMC methylation and that a
mismatch in vitamin diets between pre and postnatal period is asso-
ciated with weight gain and increased food intake into adulthood.
In summary, there is strong evidence that a mismatch of HV diet
prenatally and RV diet postnatally is associated with increased body
weight and higher energy intake into adulthood (Cho et al., 2013a,
2013b; Sanchez-Hernandez et al., 2015, 2014). There is evidence that
high concentrations of vitamin A (Sánchez-Hernández et al., 2014) and
folate (Cho et al., 2013b) postnatally have a modest eﬀect to lower
POMC methylation in those exposed to HV diet prenatally.
3.1.4. Prenatal stress
Prenatal stress (PNS) is associated with chronic disease, such as
obesity, in adulthood (Tamashiro and Moran, 2010). Epigenetic
changes could be a conduit between PNS exposures and later pheno-
type. There is indeed evidence of epigenetic changes at POMC asso-
ciated with PNS that predispose an individual to obesity when the an-
imal is exposed to an obesogenic environment, such as HFD. Paternain
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et al showed that female PNS rats fed an HFD as adults demonstrated
higher adiposity and greater insulin resistance when compared to non-
PNS controls (Paternain et al., 2012). HFD in adulthood led to increased
hypothalamic POMC expression in both PNS rats and controls, but with
an interaction between PNS, HFD and methylation at a single CpG site
in the POMC promoter after adjustment for multiple testing. This study
thus provides limited evidence that POMC methylation changes are
inﬂuenced by PNS leading to increased susceptibility to HFD and the
subsequent postnatal obese phenotype.
PNS has been shown to lead to greater weight loss in oﬀspring when
subjected to energy restriction. Boersma et al demonstrated that com-
pared to controls, PNS male and female rats showed lower food intake
and greater weight loss when subsequently exposed to activity-based
anorexia (ABA); experimental conditions where food is limited to 1.5 h
per day and a running wheel in placed in their cage postnatally
(Boersma et al., 2016). ABA induced a reduction in POMC expression
and an increased expression of NPY in all groups. There was no dif-
ference in POMC promoter methylation between groups. This study
does not support the hypothesis that POMC methylation changes are
associated with PNS. PNS does appear to inﬂuence postnatal energy
balance under conditions of ABA, though this does not appear to be
mediated by methylation changes at the POMC gene.
In summary, the study by Paternain et al. (2012), provides only
limited evidence of an interaction between PNS and POMC methylation
changes. However, both studies do provide evidence that PNS rats have
greater adiposity when fed HFD as adults though conversely are more
susceptible to weight loss under periods of nutritional scarcity. Whether
these changes are mediated by POMC epigenetic alterations (other than
DNA methylation) warrants further study.
3.1.5. Maternal drug exposure
Triclosan is a broad-spectrum antibiotic agent found in household
and personal hygiene products (US Food and Drug Administration,
2018). Exposure to the drug prenatally is thought to inﬂuence birth
weight in humans (Etzel et al., 2017), though the inﬂuence on epige-
netic changes and later phenotype is little explored. Hua et al., showed
a link between prenatal triclosan exposure and later obese phenotype in
both male and female rats. Rats exposed to Triclosan in early/mid ge-
station (gestational day 6–14) had lower birth weight, but by day 30 of
life showed increased mean POMC methylation (signiﬁcantly higher in
6 CpGs across the POMC promoter), reduced POMC expression and
subsequent early hyperphagic obesity and metabolic syndrome (Hua
et al., 2019). This study gives support to the idea of an environmental
agent acting prenatally to inﬂuence POMC methylation which is asso-
ciated with the development of obesity and metabolic syndrome later in
life.
3.2. Postnatal exposures, epigenetic alterations in the POMC gene and
phenotype
There is also evidence that postnatal factors can inﬂuence POMC
epigenetic marks and inﬂuence weight-related phenotype (see Table 2).
One possibility is that developmental plasticity continues into the
postnatal period with an epigenetic adaptive response continuing be-
yond the ‘classical’ window of fetal programming. If this is the case,
then alterations to POMC epigenetic marks in the postnatal period
would allow the organism to more accurately predict, adapt and respond
to future nutritional requirements.
Alternatively, postnatal changes may represent more widespread
alterations to the epigenome brought about by environmental factors
and may not target POMC speciﬁcally. Yet another explanation is that
epigenetic changes are due to reverse causation where postnatal phe-
notype inﬂuences the epigenome.
3.2.1. Energy excess
Overnutrition during infancy, in animals and humans, is associated
with the later development of obesity (Ojha et al., 2013). There is
evidence that POMC hypermethylation, induced by postnatal energy
excess, may suppress the satiety response by impeding the action of
peripheral signals such as leptin and insulin. This was demonstrated in
a rodent model (Plagemann et al., 2009) whereby postnatal energy
excess was induced by artiﬁcially creating ‘small litters’ (SL) of 3 pups
per mother (as opposed to 10 pups per mother). Rats placed into SL
from day 2 of life, demonstrated higher body weight, glucose, leptin
and insulin by day 7 of life (Plagemann et al., 2009). Higher POMC
promoter methylation, including in regions associated with nuclear
factor K-B (NF-KB) and Sp1 binding on the POMC gene, was observed
compared to controls (even after Bonferroni correction for multiple
testing). Sp1 binding is crucial to mediate the eﬀect of circulating leptin
via STAT3-Sp1-complex formation. There was an inverse relationship
between POMC methylation at the Sp1 binding site and POMC ex-
pression per unit of leptin and insulin, suggesting that methylation at
this site impedes the anorectic eﬀects of leptin and insulin resulting in
lower POMC expression. This study supports a link between energy
Fig. 3. An overview of one-carbon metabolism.
Key: BHMT, betaine-homocysteine methyl-
transferase; B2, riboﬂavin; B6, vitamin B-6; B12,
vitamin B-12; CBS, cystathionine-β-synthase;
CHDH, choline dehydrogenase; CTGL, cy-
stathionine-γ-lyase; DMG, dimethylglycine;
DNMT, DNA methyltransferases; GNMT, glycine-
N-methyltransferase; MAT, methionine adeno-
syltrasferase; MTHFR, methylenetetrahy-
drofolate reductase; MS, methionine synthase;
SAH, S-adenosylhomocysteine; SAHH, S-adeno-
sylhomocysteine hydrolase; SAM, S-adeno-
sylmethionine. Reproduced with permission
from Paula Dominguez-Salas, Sophie E Moore,
Darren Cole, Kerry-Ann da Costa, Sharon E Cox,
Roger A Dyer, Anthony JC Fulford, Sheila M
Innis, Robert A Waterland, Steven H Zeisel,
Andrew M Prentice, Branwen J Hennig, DNA
methylation potential: dietary intake and blood
concentrations of one-carbon metabolites and
cofactors in rural African women, The American
Journal of Clinical Nutrition, Volume 97, Issue 6,
June 2013, Pages 1217–1227, https://doi.org/
10.3945/ajcn.112.048462.
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excess in the postnatal period and epigenetic changes at transcriptional
regulatory sites in the POMC promoter.
Marco et al. (2013), used a rat over-feeding model and further de-
monstrated the interaction of POMC methylation, Sp1 binding and
POMC expression. Male rats fed an HFD from the neonatal period into
adulthood demonstrated increased weight, insulin and leptin with hy-
permethylation at 6 CpGs in the POMC promoter including at a Sp1
binding site. However, there was not the expected increase in hy-
pothalamic POMC expression despite signiﬁcantly higher levels of
leptin, Sp1 and insulin (factors associated with upregulation of POMC
expression (Balthasar et al., 2004; Qiu et al., 2014; Yang et al., 2009).
ChIP analysis demonstrated reduced Sp1 binding in the HFD group,
despite higher levels of circulating Sp1, suggesting hypermethylation
impeded the formation of the Sp1 complex. This study supports a link
between energy excess in the postnatal period and methylation changes
at CpGs near a key transcriptional regulatory site (Sp1) in the POMC
promoter.
NF-KB is released in response to both acute and chronic in-
ﬂammation. Though acute inﬂammation is associated with reduced
food intake (Grossberg et al., 2010), obesity is associated with chronic
low grade inﬂammation (Ellulu et al., 2017). RELA (v-rel re-
ticuloendotheliosis viral oncogene homologue A (avian)) is a subunit of
NF-KB. Shi et al. (2013), demonstrated that during acute inﬂammation,
male mice showed reduced appetite and increased POMC expression.
Using a STAT3 (Signal transducer and activator of transcription 3)
knock out model they demonstrated that this upregulation of POMC
was independent of the STAT3 pathway (mediated by leptin) but in-
stead RELA upregulated POMC transcription by directly binding to the
POMC promoter. In the same study, they showed that HFD male mice
(modelling the chronic inﬂammation seen in obesity) had hy-
permethylation of the POMC promoter which subsequently impeded
RELA-mediated POMC transcriptional activation. This study supports a
link between energy excess and increased methylation in the POMC
promoter but also proposes an alternative means of POMC transcrip-
tional regulation by direct binding of RELA to the promoter region.
Mahmood et al. (2013) demonstrated a potential postnatal pro-
gramming eﬀect of high carbohydrate (HC) feeds on melanocortin
system neuropeptides and adult body weight, though mediated pre-
dominantly through epigenetic changes in the NPY (neuropeptide-Y)
gene. Female rats were fed with either HC or mother’s milk (MM), and
then weaned onto standard feed from day 24. By day 16, HC rats had
higher NPY H3K9 acetylation, lower NPY gene methylation, lower
POMC gene H3K9 gene acetylation but no diﬀerence in POMC promoter
methylation. By day 100, only NPY methylation diﬀerences persisted
(with increased expression of NPY) with signiﬁcantly higher body
weight in those fed HC diet compared to those fed MM in the postnatal
period. This study suggests that a high energy diet can induce epige-
netic changes at the POMC gene but these changes do not persist be-
yond the immediate postnatal period. Importantly, sustained epigenetic
changes were only seen in the NPY gene, and not POMC.
It has been suggested that epigenetic changes could ‘predispose’ an
individual to overconsumption in an obesogenic environment (Stöger,
2008 Dec). Cifani et al., demonstrated there are epigenetic diﬀerences
in POMC and NPY, in those rats who are obesity-resistant or obesity-
prone on exposure to an obesogenic environment (Cifani et al., 2015).
Male rats were fed a high energy feed for 5 weeks and classiﬁed as to
whether they developed obesity or did not (diet induced obesity: DIO or
diet resistant: DR). The DR rats consumed less, had similar weight to
controls but also had decreased hypothalamic expression of NPY by
5weeks (with hypermethylation at one CpG in NPY) and higher ex-
pression of POMC at 21 weeks (the mean POMC methylation was sig-
niﬁcantly lower though the diﬀerence was very small (∼1%), however
there were still signiﬁcant diﬀerences at 4 CpG sites even after Bon-
ferroni correction) compared to DIO rats. This study suggests that dif-
ferent neuropeptide gene methylation and expression could account for
the divergent eating behaviour and weight gain, though overall
diﬀerences in POMC methylation were small.
There is further evidence that high energy diets induce epigenetic
changes that produce increased expression of orexigenic neuropeptides
(AgRP/NPY), overriding any increased expression of the anorectic
POMC, and leading overall to overconsumption and increased body
weight. Lazzarino et al. (2017) fed female rats a CAF diet (Cafeteria
diet, modelled on Western diet of high palatability and highly energy
dense foods) from weaning and demonstrated an increased expression
of POMC and reduced AgRP expression at the level of the ARC but in-
creased expression of AgRP/NPY in the PVN. This was accompanied by
lower methylation in the POMC promoter of the ARC and lower me-
thylation in the NPY promoter in the PVN. CAF fed rats had higher body
weight from week 10 and consistently consumed a higher energy intake
compared to controls. Of note, the methylation of CpGs associated with
Sp1 binding (thought to mediate anorectic eﬀects of leptin) were not
measured in this study. This study suggests that in response to CAF diet
epigenetic and gene expression changes eﬀect both AgRP/NPY and
POMC, though the higher energy intake observed was mediated by
higher AgRP/NPY expression in the PVN and not counteracted by in-
creased POMC expression in the ARC.
In summary, the studies by Plagemann et al. (2009), Marco et al.
(2013) and Zheng et al. (2015) provide the strongest evidence for nu-
tritionally-driven postnatal changes to POMC epigenetic marks. How-
ever, it is not clear if the diet itself or the increased body weight leads to
the epigenetic diﬀerences observed. Other studies suggest that AgRP/
NPY genes are more susceptible to postnatal overnutrition than POMC
and may be more implicated with the postnatal phenotype (Mahmood
et al., 2013; Lazzarino et al., 2017).
3.2.2. Energy restriction
There are data from humans that suggest periods of extreme ca-
loriﬁc restriction may lead to remission of type 2 diabetes mellitus
(Lean et al., 2018) and a sustained reduction in BMI (Willi et al., 2004)
long after the end of dietary intervention. Animal models suggest this
‘metabolic memory’ may be mediated via epigenetic changes in the
appetite regulating neuropeptides. Liu et al. (2013), explored if periods
of caloriﬁc restriction in the post weaning period could mitigate the
development of obesity in adult life associated with SL during suckling.
Male rats given moderate caloriﬁc restriction (24% reduction in daily
caloriﬁc intake for 49 days) in the post weaning period, showed com-
parable food intake and slower weight gain compared to controls when
subsequently fed ad libitum, such that they did not reach the weight of
controls by day 140 of life. Furthermore, they had similar levels of
insulin, leptin and expression of NPY and POMC to controls. In both
control and caloriﬁc restriction groups there was increased methylation
in the NPY promoter at a CpG important for E2F (E2 Factor) binding,
compared to those from SL with no restriction. E2F is a transcription
factor known to regulate NPY expression. There were no diﬀerences in
POMC promoter methylation between the groups. This study demon-
strates that a period of caloriﬁc restriction may attenuate the hyper-
phagia and obese phenotype associated with SL, though suggests that
this does not appear to be mediated by alterations in POMC gene me-
thylation.
However, Unnikrishnan et al., reported 65% lower hypothalamic
POMC expression following short term dietary restriction in male mice
(Unnikrishnan et al., 2017). These alterations in POMC gene expression
persisted even after 2months of ad libitum feeding. There was no as-
sociated diﬀerence in DNA methylation at the POMC promoter, though
DNA methylation was analysed from whole hypothalamic tissue and
not speciﬁcally the ARC where POMC is expressed in the hypothalamus.
These two studies suggest that postnatal energy restriction does not
lead to changes in POMC methylation but predominantly eﬀects me-
thylation marks at NPY (similar to studies of postnatal energy excess
(Mahmood et al., 2013; Lazzarino et al., 2017). Reported alterations in
POMC gene expression could be related to other epigenetic processes
not measured in these studies.
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3.2.3. Fatty acids
Diets high in n–6 polyunsaturated fatty acids (PUFA) found in foods
such as sunﬂower oil, and low in n–3 PUFA (found in ﬁsh oil for ex-
ample) have been implicated in a number of chronic diseases including
obesity (Ailhaud et al., 2006). N-3 PUFA has been shown to reduce
leptin expression (Ukropec et al., 2003), which is elevated in obesity
due to the increased adipose tissue mass. Leptin regulates the anorectic
actions of POMC via the long form leptin receptor on POMC neurons,
and it has been postulated that elevated leptin in obesity represents a
form of leptin resistance (Myers et al., 2012). Fan et al., demonstrated
that the addition of n-3 PUFA to the diet of obese male mice normalised
POMC expression and leptin to comparable levels seen in controls (Fan
et al., 2011). N-3 PUFA fed mice had lower weight compared to those
fed n-6 PUFA. The changes in gene expression were not related to a
diﬀerence in methylation in either POMC or the leptin promoter from
adipose tissue.
Conjugated linoleic acid (CLA) is a fatty acid associated with the
development of metabolic disease (Tsuboyama-Kasaoka et al., 2000)
and has been implicated in postnatal programming (Poulos et al., 2001)
in murine models. There is evidence from Zhang et al. (2014) to suggest
that postnatal nutritional exposure to CLA causes POMC promoter hy-
permethylation, preventing Sp1 complex formation which in turn leads
to reduced POMC expression and an increase in food intake. Lactating
mice were fed a diet rich in either CLA or LA (linoleic acid) which
altered milk composition such that CLA fed mice had increased milk
glucose and insulin, lower milk lactose and triglycerides and altered
fatty acid composition compared to LA fed mice. CLA fed pups had
signiﬁcantly lower POMC expression compared to LA fed pups with
hypermethylation of two promoter CpGs. This region of the POMC
promoter is at the location of a Sp1 binding site and ChIP assays de-
monstrated reduced Sp1-POMC promoter complex formation in CLA fed
pups. Interestingly, CLA fed pups had low SAH (formed after a methyl
group is removed from SAM in methylation reactions, see Fig. 3) and it
was suggested this may explain the observed hypermethylation in this
group. In the same study, CLA fed mice initially had lower body weight
and restricted growth, but increased food intake. However, they were
heavier as adults with impaired glucose homeostasis compared to
controls. This study does support a modulatory eﬀect of dietary CLAs on
the POMC methylation and gene expression with an association with
obesity in later life.
There is limited evidence that postnatal dietary fatty acids inﬂuence
POMC gene methylation. However, Zhang et al. (2014) provide the
strongest link with dietary CLAs associated with alterations at key
regulatory regions of the POMC promoter.
3.2.4. Leptin
Due to leptin’s known association with upregulation of POMC, Palou
et al investigated if leptin treatment could inﬂuence postnatal pro-
gramming of hypothalamic hormones including POMC (Palou et al.,
2011). Leptin treatment in the suckling period led to lower body weight
and food consumption in adulthood compared to controls. After the
suckling period, male rats were fed either normal diet or HFD. At a CpG
position close to the Sp1 binding site, leptin-treated rats demonstrated
signiﬁcantly higher methylation when fed a normal diet and lower
methylation when fed HFD (compared to non-leptin treated animals).
However, there were no signiﬁcant correlations between POMC me-
thylation and POMC expression. The authors note these observations
should be treated with caution until conﬁrmed by other independent
studies and signiﬁcance was only reached when comparing individual
groups (as overall there was a non-signiﬁcant interaction using two-
way ANOVA tests).
3.3. Other epigenetic regulatory factors and weight-related phenotypes
3.3.1. Methyl CpG binding protein (Mecp2)
Mecp2 was thought to be a repressor of POMC activity acting by
recruitment of a repressor complex (Wu et al., 2014; Gangisetty et al.,
2014) to methylated DNA. However, a study by Wang et al found that
Mecp2 can act as a transcriptional activator in the hypothalamus (Wang
et al., 2014). Male mice with a speciﬁc Mecp2 knock out (KO) in POMC
neurons had higher body weight, energy intake, leptin and body fat
percentage. The Mecp2 KO mice had higher POMC promoter methyla-
tion and lower POMC expression. Co-transfection of wild type Mecp2
and cAMP responsive element binding protein 1 (CREB1) led to in-
creased POMC promoter activity, signiﬁcantly more than when trans-
fected with Mecp2 or CREB1 alone. This suggests that the activating
properties of Mecp2 are dependent on an interaction with CREB1 to
increase POMC expression. In contrast to previous studies (Wu et al.,
2014; Gangisetty et al., 2014), this study speciﬁcally altered Mecp2
expression in POMC neurons and therefore better demonstrates the
eﬀect in this neuronal group.
3.4. Summary of evidence from animal studies
From the evidence in animal models, it is clear there is a complex
relationship between pre- and postnatal exposures that inﬂuence epi-
genetic processes associated with the POMC gene.
Epigenetic processes and marks are sensitive to prenatal nutritional
and environmental exposures and have a consequence on later adult
phenotype. There is evidence from these animal studies that supports
the PAR hypothesis that mismatched in utero and ex utero environments
are associated with obesity and poor metabolic health and can be to
some degree explained by epigenetic changes in POMC. For example,
there is considerable evidence that prenatal exposures to energy excess
(Marco et al., 2014, 2016; Gali Ramamoorthy et al., 2018) and peri-
conceptional and early pregnancy energy restriction (Stevens et al.,
2010; Begum et al., 2012) have diﬀerent eﬀects on POMC epigenetic
marks and are associated with postnatal phenotype. A mismatch in pre
and postnatal vitamin levels have been shown to be associated with
higher body weight and increased food intake (Cho et al., 2013a,
2013b; Sanchez-Hernandez et al., 2015, 2014), and there is modest
eﬀects of vitamin A (Sánchez-Hernández et al., 2014) and folate (Cho
et al., 2013b) to lower POMC methylation postnatally. Though limited
to one study (Hua et al., 2019), the modulatory eﬀect of Triclosan on
POMC methylation appears signiﬁcant and is strongly associated with
obesity in adulthood.
The evidence of postnatal exposures inﬂuencing POMC epigenetic
marks is more limited. Evidence from Plagemann et al. (2009) and
Marco et al. (2013) provide the strongest link between postnatal energy
excess and changes to DNA methylation at POMC, however other stu-
dies report that AgRP/NPY genes appear more sensitive than POMC to
postnatal energy imbalance (Mahmood et al., 2013; Lazzarino et al.,
2017; Liu et al., 2013; Unnikrishnan et al., 2017). The study by Zhang
et al. (2014) suggests that dietary CLAs are the strongest speciﬁc nu-
tritional factor to mediate methylation changes at POMC gene post-
natally.
It is important to consider the potential for reverse causation when
interpreting results from epigenetic studies. An approach to minimising
the potential for reverse causation eﬀects is to measure epigenetic
marks (e.g. DNA methylation) prior to manifestation of the disease or
phenotype. One advantage of animal studies is the ability to access
functionally relevant tissue (such as ARC samples when examining
POMC), however this may prevent assessment of epigenetic marks prior
to the development of a particular phenotype as the animal is eu-
thanised. To circumvent this, researchers often use subgroups of ani-
mals who are euthanised at diﬀerent time points. Marco et al. (2014),
euthanised a proportion of rodents on weaning and maintained a group
into adulthood allowing comparisons of methylation before the adult
phenotype developed. In this study, the same POMC promoter hy-
permethylation was seen at weaning and in adulthood suggesting that
the methylation predated the development of the adult phenotype.
In all of the animal studies, samples harvested were either from the
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whole hypothalamus, ARC or PVN. One issue with analysing whole
hypothalamus is that cell heterogeneity (i.e. the presence of cells that
are not exclusively ARC or PVN cells) may dampen any positive signal
and could risk type 2 errors, or conversely increase the risk of type 1
errors in the case of confounding due to changing cell populations be-
tween treatment groups.
There are a number of studies which report no association between
DNA methylation and POMC expression, suggesting that other epige-
netic processes could drive diﬀerential expression. However, studies
that accounted for leptin or insulin levels when interpreting POMC gene
expression more often found signiﬁcant diﬀerences (Plagemann et al.,
2009). Mechanistic studies are required to fully understand how al-
terations in POMC epigenetic pathways inﬂuence gene expression or
phenotype, for example by assessing the eﬀect of gene ‘knock out’ or
‘knock down’ models that target speciﬁc epigenetic processes. An ex-
emplar of this approach is demonstrated by Wang et al. (2014) where
the mechanism by which Mecp2 and CREB1 inﬂuence POMC methy-
lation, gene expression and phenotype was elucidated using an MECP2
knock out in mouse POMC neurons.
It is important to note that whilst many studies did account for
multiple comparisons (e.g., Gali Ramamoorthy et al., 2018; Marco
et al., 2014, 2016, 2013; Begum et al., 2012; Paternain et al., 2012;
Boersma et al., 2016; Plagemann et al., 2009; Cifani et al., 2015; Liu
et al., 2013; Unnikrishnan et al., 2017; Palou et al., 2011) some studies
did not (Desai et al., 2016; Hua et al., 2019; Shi et al., 2013; Mahmood
et al., 2013; Lazzarino et al., 2017; Fan et al., 2011; Zhang et al., 2014).
The need for multiple testing corrections can be context dependent
since methylation levels within genomic regions such as CpG islands
may be correlated, suggesting that a correction isn’t justiﬁed.
4. Human studies
The establishment and maintenance of cell-speciﬁc gene expression
proﬁles is a key function of epigenetic processes, and epigenetic marks
including DNA methylation are therefore generally tissue-speciﬁc. Thus
a signiﬁcant challenge in human epigenetic studies is selecting relevant
accessible tissue to examine. Peripheral blood cell (PBC), buccal epi-
thelial cells (BEC) or hair follicles are often used as they are easily
accessed and minimally invasive. However, the degree of tissue dis-
cordance in DNA methylation can be a problematic and limit how much
can be inferred from an accessible tissue (such as PBC) about the tissue
of interest (i.e. the hypothalamus for POMC’s regulation of energy
balance). In this respect, the use of human cadaveric samples can be
useful to understand the correlation in methylation between the ac-
cessible tissue and the tissue of interest (Kühnen et al., 2016a). An as-
sessment of two or more samples originating from diﬀerent germ layers
e.g. PBC (mesoderm) and BEC (ectoderm) can be used to identify sys-
temic methylation patterns.
4.1. Nutritional inﬂuences on the POMC gene – Evidence in humans
As with animal studies (see Tables 1 and 2), there is evidence in
humans that POMC gene methylation is associated with nutrition in
early pregnancy and diet into adulthood (see Table 3).
4.1.1. Inﬂuence of periconceptional diet on the POMC gene
A body of work in mouse and humans has focussed on nutrition-
associated changes in DNA methylation at metastable epialleles (MEs).
MEs are epigenetic loci with characteristic methylation patterns that
are established early in embryonic development (Rakyan et al., 2002)
that are often associated with neighbouring transposable elements
(Waterland and Jirtle, 2003).
The most robust evidence for MEs comes from the Agouti viable
yellow (Avy) (Waterland and Jirtle, 2003) and Axin-fused (AxinFu)
mouse models (Waterland et al., 2006). For example, isogenic Avy mice
show variable agouti expression dependent on DNA methylation at a
cryptic promoter within an IAP (intracisternal A particle (IAP)) up-
stream of the agouti gene. A maternal diet rich in methyl donor nu-
trients folate, B12, choline and betaine gives rise to increased methy-
lation at the IAP in Avy oﬀspring (Waterland and Jirtle, 2003). The
degree of methylation is associated with phenotype such that hypo-
methylation leads to increased ectopic agouti expression, yellow fur
and an obese phenotype. In contrast, hypermethylation at the same
region is associated with reduced expression and a lean mouse with
brown or mottled fur.
A number of human studies have demonstrated associations be-
tween periconceptional diet and DNA methylation at putative MEs
(Finer et al., 2016; Silver et al., 2015; Dominguez-Salas et al., 2014),
and interestingly there are multiple lines of evidence, including sensi-
tivity to maternal nutrition, that POMC is a putative human metastable
epiallele.
Firstly, as with the agouti mouse, there is evidence that the methy-
lation state of the POMC gene in humans is sensitive to maternal diet in
early pregnancy. Mother-child paired blood samples from a Gambian
cohort demonstrated an association between early pregnancy one-
carbon metabolite concentrations in maternal plasma and oﬀspring PBC
POMC methylation (Kühnen et al., 2016a). Speciﬁcally, there was a
signiﬁcant negative correlation for SAH and positive correlations with
betaine and the ratio of SAM to SAH at a region spanning the intron2/
exon3 boundary of the POMC gene. Oﬀspring DNA methylation was
also associated with Gambian season of conception, with lower DNA
methylation at the POMC VMR (variably methylated region) in children
conceived in the dry season compared to those conceived in the rainy
season (Kühnen et al., 2016a). In contrast to animal models of maternal
overnutrition (Gali Ramamoorthy et al., 2018; Marco et al., 2014;
Zheng et al., 2015), neither maternal body weight at conception nor
weight change in pregnancy correlated with oﬀspring POMC methyla-
tion (Kühnen et al., 2016a).
Secondly, POMC methylation appears to be set very early in em-
bryonic development. Evidence for this comes from post mortem sam-
ples that demonstrate POMC DNA methylation is highly correlated
across tissues originating from diﬀerent germ cell layers i.e. brain –
ectoderm, and kidney or PBC – mesoderm (Kühnen et al., 2016a). This
suggests the methylation state was set prior to the separation of the
germ layers at gastrulation; the canonical feature of an ME.
Thirdly, methylation at the POMC VMR is thought to be largely
independent of genotype, at least in cis, with similar methylation pat-
terns across genetically diverse cohorts (Kühnen et al., 2016a). It is
interesting to note that MEs were originally identiﬁed in isogenic mice
and deﬁned as being independent of genotype. While current evidence
suggests this may be true at the POMC VMR, it has recently been pro-
posed that MEs may be sensitive both to environment and local geno-
type (Kessler et al., 2018).
Fourthly, POMC methylation is associated with the presence of
neighbouring transposable elements. A considerable proportion of the
human genome consists of transposable elements such as retro-
transposons. The most common retrotransposons in the human genome
are Alu elements (Price et al., 2004). Kühnen et al., observed three Alu
elements in intron 2 (Kuehnen and Krude, 2012) of the POMC gene (see
Fig. 1). These Alu elements are only found in humans and higher pri-
mates (e.g. chimpanzees) and are not found in more distant primates or
mice. Those species with Alu elements, demonstrated the same hy-
permethylation pattern of intron 2, however those without Alu ele-
ments showed hypomethylation (Kuehnen et al., 2012) suggesting that
the presence of Alu elements drives hypermethylation in this region.
This demonstrates a similar pattern seen in MEs where alteration in
gene expression is driven by methylation at retrotransposons, similar to
that seen with the IAP retrotransposon in the Avy mouse (Morgan et al.,
1999).
Importantly, assessment of POMC methylation in new-born and
adolescent blood samples demonstrated that the methylation pattern
appears stable, suggesting that associations with postnatal phenotypes
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are not driven by reverse causation eﬀects (Kühnen et al., 2016a). This
is further supported by Yoo et al. (2014), who assessed POMC methy-
lation in a longitudinal birth cohort and showed that methylation was
highly correlated from birth to childhood (r= 0.80, p= 0.0001).
4.1.2. POMC methylation and diet in adulthood
SFA (saturated fatty acid) diets are associated with increased visc-
eral and hepatic steatosis and PUFA (polyunsaturated fatty acids) diets
are associated with increased lean mass (Rosqvist et al., 2014). There is
evidence that these diets may inﬂuence DNA methylation. The LIPO-
GAIN study (Perﬁlyev et al., 2017), a double-blind randomised con-
trolled trial, gave healthy normal weight adults 7 weeks of a daily
muﬃn either high in SFA (n= 17) or PUFA (n=14). Adipose tissue
samples were taken at baseline and at the end of intervention and used
for methylation analysis. There was increased global methylation in
adipose tissue following both diets. However, POMC was one of a
number of genes where mean methylation in adipose tissue increased
only in response to PUFA and not SFA treatment.
4.2. POMC methylation and weight-related phenotypes
The majority of evidence related to POMC epigenetics and weight
regulation has come from animal models. However, more recently,
studies have explored the role of epigenetic regulation of POMC and
weight-related phenotypes in humans (see Table 3).
4.2.1. Obesity
Kuehnen et al. (2012) were ﬁrst to examine the relationship be-
tween POMC DNA methylation and obesity in humans. In a case control
study comparing 71 obese and 36 normal weight children, they re-
ported a signiﬁcant diﬀerence in average PBC POMC DNA methylation
at a VMR overlapping the boundary of intron2/exon3 (average me-
thylation 25% normal weight vs. 40% obese, p < 0.001). This ﬁnding
was replicated in a second case control study in children with com-
parable results. An association between POMC hypermethylation at the
VMR and BMI was demonstrated in both PBC and cadaveric MSH
neurons in adults (Kühnen et al., 2016a). The eﬀect size was largest in
MSH neurons, where a 10% increase in methylation was associated
with a 2.8 kg/m2 increase in BMI (Kühnen et al., 2016a). Kühnen et al.,
also demonstrated that hypermethylation at the VMR decreased histone
acetyltransferase P300 binding at the VMR (see Fig. 1), leading to re-
duced expression of POMC from PBC. P300 is an enzyme that promotes
transcription through histone acetylation (Kuehnen et al., 2012). There
was no association between BMI and DNA methylation in the CpG is-
land in the POMC promoter region (Kuehnen et al., 2012).
The association of BMI and POMC methylation appears dependent
on the region of the gene studied. For example, a recent study by Ács
et al. (2017) examining 82 obese children aged 3–18 years old did not
show any correlation between PBC POMC methylation and BMI. This
study examined DNA methylation at exon 1 of the POMC gene rather
than the intron2/exon3 region studied by Kühnen et al. (2016a). An-
other possible explanation for the lack of correlation between POMC
methylation and BMI is that this study examined obese children with
BMI > 95th percentile, and there may not be a strong correlation with
methylation and BMI at these extremes of weight compared to com-
parisons made with normal weight individuals or the general popula-
tion. Furthermore, Yoo et al. (2014) reported no signiﬁcant association
between BMI or percentage body fat with POMC methylation in exon 3.
A possible explanation is that the genomic region studied is down-
stream of the region associated with P300 binding (Kuehnen et al.,
2012, 2016). In this study, PBC POMC methylation (at 4 CpG sites in
exon 3) measured in cord blood was subdivided into categories of either
high (> 90th centile), mid or low (< 10th centile) methylation. Birth
weights (p= 0.01) and ponderal indices (p=0.01) in the high POMC
methylation group were signiﬁcantly lower than in the mid-methyla-
tion group, but there were no diﬀerences in BMI z-score or percentage
body fat between the groups by mid-childhood. It should be noted that
there were only 10 children in each of the high and low groups and no
clear justiﬁcation was given for splitting the participants into methy-
lation categories, rather than using methylation as a continuous vari-
able. In a recent case control study of 79 controls and 41 overweight/
obese children aged 7–9 years, Kwon et al. (2018) compared PBC POMC
methylation (4 CpG sites in exon 3 and a similar region to Yoo et al.
(2014) and reported signiﬁcantly lower methylation in the overweight/
obese groups compared to normal weight individuals. This genomic
region is downstream from intron2/exon3 border and again would not
have included the region associated with P300 binding. Though sta-
tistically signiﬁcant, mean diﬀerences in methylation were small, for
example the methylation diﬀerence at POMC CpG site 2 was 50.3%
(normal weight) vs 49.1% (overweight/obese), p < 0.001. These dif-
ferences highlight the need to study deﬁned CpGs and it should be
noted that there is limited coverage of the regions described in the
studies above on methylation arrays such as the Illumina EPIC Array.
As mentioned above, there is evidence that POMC methylation is
stable through infancy into adolescence and that hypermethylation at
POMC may predate the onset of obesity (Kuehnen et al., 2012; Yoo
et al., 2014). Kühnen et al., examined PBC DNA from individuals aged 5
or 13 years who later became obese and 8 of 21 individuals had the
hypermethylation variant many years before the onset of obesity, im-
plying that POMC hypermethylation is not merely a consequence of
increased body mass (Kuehnen et al., 2012).
In summary, the strongest evidence of an association between
POMC methylation and BMI comes from the case control studies of
Kuehnen et al. (2012) and Kühnen et al. (2016a). Other studies examine
diﬀerent regions of the gene where there is limited evidence for an
association with body weight (Yoo et al., 2014; Kwon et al., 2018).
4.2.2. Metabolic outcomes
There are reported associations between POMC methylation (in
exon 3) and metabolic outcomes that appear independent of BMI or
adiposity. Yoo et al. (2014), reported signiﬁcantly higher fasting tri-
glycerides (TG) (though not total cholesterol) in children aged
7–9 years in the high and middle level POMC methylation groups
compared to the low methylation group; high vs low (TG=113.89mg/
dl vs 57.97mg/dl, p= 0.03) and middle vs low (TG=67.29mg/dl vs
57.97mg/dl, p= 0.01). This is despite there being no diﬀerence in BMI
or percentage body fat between the groups. Kwon et al. (2018), re-
ported signiﬁcant association between methylation at a CpG site in
exon 3 and lower HDL (high density lipoprotein) cholesterol levels
(β=−0.23, p=0.048) after adjusting for age, gender and BMI. In-
terestingly, polymorphisms in melanocortin signalling pathways have
been linked to altered lipid metabolism, independent of body habitus
suggesting a possible distinct causal mechanism (Perez-Martinez et al.,
2011).
There is evidence of an association between elevated insulin and
increased POMC methylation. Yoo et al. (2014), demonstrated higher
fasting insulin levels in the high and middle POMC methylation groups
compared to low methylation group; high vs low (insulin 10.13 µIU/ml
vs 7.1 µIU/ml vs p=0.05) and mid vs low (insulin= 7.64 µIU/ml vs.
7.1 µIU/ml, p= 0.02). A non-signiﬁcant trend to greater insulin re-
sistance (homeostatic model assessment of insulin resistance (HOMA-
IR)) between high (p= 0.09) and mid (p= 0.06) groups compared to
low methylation group was also observed, and no signiﬁcant diﬀerence
in blood glucose was reported between the diﬀerent methylation
groups.
4.2.3. POMC methylation as a predictor of successful weight loss
intervention
Crujeiras et al. (2013) explored the utility of POMCmethylation as a
potential biomarker for success in weight loss interventions. Eighteen
men enrolled in a dietary intervention programme who successfully lost
more than 5% of their body weight were reviewed at 32 weeks post
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intervention. Participants were divided into two groups: regainers (re-
gained more than 10% body weight) and non-regainers (regained less
than 10% body weight). Higher POMC promoter methylation was seen
in regainers vs. non-regainers (p= 0.02) with a percentage body
weight regain to methylation correlation coeﬃcient of 0.6. Interest-
ingly, there was an opposite trend for NPY gene methylation.
4.2.4. POMC methylation and anorexia nervosa
Individuals with anorexia nervosa (AN) reportedly have low levels
of folate (Castro et al., 2004) and elevated homocysteine (Frieling et al.,
2005); important components of one-carbon metabolism pathways (see
Fig. 3). Furthermore, lower global DNA methylation has been reported
in AN compared to normal weight controls (Frieling et al., 2007). This
combined with POMC’s inﬂuence on appetite regulation makes the gene
a key candidate to explore epigenetic inﬂuence on the development of
AN. Ehrlich et al. (2010), explored the relationship of PBC POMC
promoter DNA methylation and expression of POMC mRNA in both
acutely admitted and weight recovered women with AN and normal
weight female controls. Mean POMC promoter methylation was neither
diﬀerent across nutritional states nor across disease groups. POMC
mRNA expression was decreased in those with undernutrition and hy-
poleptinaemia. The study demonstrated that expression of POMC is
linked to nutritional state rather than a distinct feature of AN.
Ehrlich et al. (2012) later conﬁrmed observations from the earlier
study that there was no eﬀect in women of undernutrition or a diag-
nosis of AN on PBC POMC promoter DNA methylation. However, they
did observe signiﬁcant associations between cigarette smoking and PBC
POMC DNA methylation. Overall PBC POMC promoter methylation was
negatively associated with average number of cigarettes smoked per
day (ρ=−0.287, p= 0.002). Nicotine is known to induce hypophagia
and this is thought to be mediated through POMC neuronal activation
(Mineur et al., 2011; Huang et al., 2011). Smokers have a lower body
weight compared to non-smokers (Chiolero et al., 2008) and weight
gain following smoking cessation has been observed (Filozof et al.,
2004). This is a cross sectional study and as such the direction of
causality between smoking and POMC methylation is not known.
In summary, these studies do not suggest an association with POMC
methylation and AN diagnosis.
5. Summary of evidence from human studies
There is evidence in both children and adults that hypermethylation
at the POMC VMR of intron2/exon3 is associated with obesity
(Kuehnen et al., 2012, Kühnen et al., 2016a). There are a number of
lines of evidence to suggest that this region of the POMC gene is a
putative human ME and inﬂuenced by periconceptional nutritional
status. An association between POMC gene methylation and body
weight was not replicated in other studies that examined diﬀerent re-
gions of the gene (Yoo et al., 2014; Ács et al., 2017; Kwon et al., 2018).
Results from two studies in children show an association between
POMC methylation in exon 3 and altered levels of lipids (Yoo et al.,
2014; Kwon et al., 2018). There is also preliminary evidence in children
that POMC methylation is associated with elevated fasting insulin (Yoo
et al., 2014). Crujeiras et al. (2013), report an association between
hypermethylation in the POMC promoter and weight regain after a
weight management intervention which demonstrates how POMC me-
thylation measurement could inform clinical risk stratiﬁcation and help
guide tailored interventions.
Cell speciﬁc methylation patterns in heterogenous samples are a
potential confounder in epigenetic studies and are generally accounted
for in epigenome-wide association studies by adjusting for cell com-
position estimates derived from the DNA methylation data itself
(Teschendorﬀ and Zheng, 2017). The region of intron2/exon3 de-
scribed by Kuhnen et al is a putative ME, and as such demonstrated
cross-tissue concordance in DNA methylation patterns in tissues derived
from all 3 germ layers, notably between PBC and the hypothalamus
(Kühnen et al., 2016a). Therefore, in this instance correcting for cell
composition should not be necessary as the methylation pattern is
thought to be systemic. The only human study to correct for cell com-
position was Perﬁlyev et al. (2017) who used a reference-free method to
correct for potential diﬀerences in adipose tissue cell type composition.
Furthermore, a comparison of POMC methylation in the promoter or
exon 1 between the hypothalamus and PBC has not been made before.
Periconception and gestation represent key windows where there is
the potential for the prenatal environment to inﬂuence epigenetic re-
programming. However environmental and nutritional factors may in-
ﬂuence DNA methylation throughout adult life (Martin and Fry, 2018).
For example, methylation at a number of POMC CpGs was associated
with PUFA diet in a study in adults as described above (Perﬁlyev et al.,
2017). Thus while there is evidence that the POMC ME region may be
stable from periconception to late adolescence (Kühnen et al., 2016a;
Yoo et al., 2014), sensitivity to speciﬁc postnatal factors, and stability
beyond this period warrants further study.
Further study is also needed to establish causative links between
POMC methylation, altered gene expression and subsequent phenotype.
Though Kuehnen et al. (2012), did see lower expression of POMC in
PBC from hypermethylated individuals many studies do not examine
POMC expression (Yoo et al., 2014; Crujeiras et al., 2013; Perﬁlyev
et al., 2017; Ács et al., 2017; Kwon et al., 2018) or ﬁnd no association
between methylation and expression (Ehrlich et al., 2010). Exploration
of how POMC methylation could inﬂuence energy consumption or the
satiety response has also not been studied before in humans.
5.1. Transgenerational inheritance of epigenetic marks at the POMC gene
Maternal exposures before and during pregnancy including en-
vironmental (e.g. toxins or stress) or nutritional factors can induce
epigenetic changes in the oﬀspring. In this case transmission of epige-
netic changes is referred to as inter-generational epigenetic inheritance
(Heard and Martienssen, 2014). In exposed mothers (F0), developing
oﬀspring (F1) and their germ cells (F2) are also exposed. Transmission
of epigenetic changes resulting from maternal exposure in F0 that
persists into the F3 generation or beyond (i.e. no direct exposure) is
termed transgenerational inheritance. In contrast, where epigenetic
changes result from an exposure in F0 males, eﬀects in F1 are inter-
generational whereas those apparent in F2 and beyond will be trans-
generational (Heard and Martienssen, 2014). Evidence for trans-gen-
erational epigenetic inheritance in humans is currently lacking and may
be extremely rare due to epigenetic reprogramming at conception and
during germ cell development (Horsthemke, 2018).
Evidence for human inter-generational inheritance through the
maternal line has been described above. There is provisional evidence
from animal and human studies to suggest POMC epigenetic marks may
be transmitted across generations and mediated via the paternal line.
Firstly, evidence from animal models on the eﬀect of fetal alcohol ex-
posure on POMC epigenetic marks suggests the potential for transge-
nerational epigenetic inheritance via the male germline. Secondly,
evidence from family trios in humans demonstrates a signiﬁcant cor-
relation between oﬀspring PBC POMC methylation and paternal, but
not maternal POMC methylation.
5.1.1. Fetal alcohol syndrome (FAS) and epigenetic inheritance
Recent studies have implicated a role for appetite regulating neu-
ropeptides (including POMC) in alcohol dependence and craving
(Hillemacher et al., 2010; Fortuna, 2010). POMC promoter methylation
has been shown to be associated with craving in those with alcohol
dependency (Muschler et al., 2014, 2010). In human studies, paternal
alcohol dependency has been associated with alterations in the hy-
pothalamic-pituitary axis including changes to ACTH secretion (a de-
rivative of POMC) in oﬀspring (Hernandez-Avila et al., 2002;
Zimmermann et al., 2004). FAS is seen more frequently in the F2
generation of an alcohol abusing mother (i.e. her grandchildren)
T. Candler, et al. Frontiers in Neuroendocrinology 54 (2019) 100773
14
compared to F2 controls (Kvigne et al., 2008). Govorko et al. (2012)
explored the possibility of intergenerational or transgenerational eﬀects
from alcohol exposure in a rat model by establishing two germlines: (1)
breeding male fetal alcohol exposed rats and their male oﬀspring with
unexposed females and (2) breeding female fetal alcohol exposed rats
and their female oﬀspring with unexposed males. Hypermethylation of
the POMC promoter and reduced POMC expression were seen in both
female and male oﬀspring in the F1 generation (of alcohol consuming
mothers), but this pattern continued in male progeny in F2 and F3 from
the male germline only. Thus a transgenerational eﬀect was only seen
via the male exposed germline. POMC promoter methylation was
higher in sperm of male rats (F1-F3) from the male exposed germline
suggesting a possible mechanism of epigenetic inheritance via methy-
lation diﬀerences in the sperm. It is postulated that maternal fetal al-
cohol exposure to the developing progeny leads to transgenerational
epigenetic transmission through the male germline thereafter (Mead
and Sarkar, 2014).
Interestingly, maternal supplementation with choline (a one-carbon
metabolite) altered the epigenome of the oﬀspring such that POMC
methylation and expression, and DNMT1 and Mecp2 levels were no
diﬀerent to non-alcohol exposed rats (Bekdash et al., 2013). It is known
that alcohol interferes with one-carbon metabolism (Fowler et al.,
2012) and therefore it seems intuitive to consider supplementation to
normalise the levels. Additionally, giving the alcohol consuming preg-
nant rat either DNMT1 inhibitor or HDAC inhibitor reversed the me-
thylation and expression changes in the oﬀspring caused by prenatal
alcohol exposure, suggesting a potential for future interventions
(Govorko et al., 2012). This demonstrates an interesting point of prin-
ciple, albeit in rats, that changing the metabolome during gestation can
alter the oﬀspring epigenome in relation to POMC and mitigate the
eﬀects of alcohol. Were similar eﬀects to be evident in humans, this
could lead to a major new approach in preventative medicine with
targeted maternal nutritional interventions to favourably inﬂuence the
oﬀspring’s epigenome and break the intergenerational risk of diseases
like obesity, as suggested by observed links between maternal con-
centrations of one-carbon metabolites, POMC methylation and obesity
in humans (Kühnen et al., 2016a).
5.1.2. Human family trios
Kühnen et al. (2016a) examined 47 mother-father-oﬀspring trios
and demonstrated signiﬁcant correlation with oﬀspring PBC POMC
methylation and the father’s PBC POMC methylation but not the mo-
ther’s, suggesting a potential intergenerational inﬂuence from the fa-
ther. However, sperm methylation at this region was signiﬁcantly lower
than PBC, suggesting that the apparent paternal inheritance of epige-
netic marks seen in the oﬀspring was not mediated through sperm
methylation. One potential mechanism is through modiﬁcations to
sperm RNAs (Chen et al., 2016).
5.1.3. Y chromosome-linked patriline inheritance
Studies suggest a possible link between POMC expression, methy-
lation and areas of the Y chromosome. The non-paring region of the Y
chromosome (YNPAR) is exclusively transmitted between fathers and
sons and includes functional genes such as SRY (sex determining re-
gion). Previous studies have suggested a possible interaction between
SRY-androgen receptor binding and POMC methylation (Muschler
et al., 2014). A study in mice has demonstrated a signiﬁcant YNPAR
inﬂuence on brain β – endorphin (a derivative of POMC, see Fig. 1)
levels (Botbol et al., 2011), suggesting a possible interaction with ge-
netic polymorphisms in YNPAR on β – endorphin expression. Alter-
natively, it has been postulated that epigenetic changes on the YNPAR
chromosome (for example caused by alcohol exposure) may inﬂuence
POMC expression and/or methylation in the oﬀspring and be a poten-
tial mechanism for epigenetic inheritance via the male line (Sarkar,
2016).
6. Conclusions
POMC is a key mediator of satiety and perturbations in the mela-
nocortin system have been associated with dysregulation of energy
balance. In animal models POMC gene methylation has been shown to
be inﬂuenced by the prenatal and postnatal environment and associated
with subsequent weight and appetite related phenotype in adulthood.
In humans periconceptional nutrition has been associated with oﬀ-
spring methylation at POMC. Human studies have often demonstrated
contradictory associations between POMC methylation and BMI and
these appear to be dependent on the region of the gene studied.
Therefore care should be exercised when selecting genomic regions for
study. More prospective studies are needed to examine the inﬂuence of
POMC DNA methylation on energy balance. Early studies suggest that
POMC is an interesting candidate for exploring inter and transgenera-
tional epigenetic inheritance in humans and future research should
elucidate potential mechanisms for this.
There are potential clinical applications for using POMC epigenetic
testing as a biomarker for early identiﬁcation of obesity risk and as a
predictor of response to obesity interventions. There are also potential
pharmacological options with Setmelanotide, a MC4R agonist, de-
monstrating success in treating those with POMC deﬁciency (Kühnen
et al., 2016b), although it is yet to be established if this could prove an
option for those with POMC hypermethylation. Looking to the future, a
better understanding of nutritional factors inﬂuencing the epigenetic
regulation of POMC could pave the way for maternal and paternal
nutritional interventions that would provide a more favourable epi-
genotype, so reducing the risk of obesity in the next generation.
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